Published: Apr 16, 2026
Written by Klarity Editorial Team
Published: Apr 16, 2026

You’re already seeing it in your practice: patients struggling with weight gain from antipsychotics, mood stabilizers that packed on 40 pounds, or that hollow feeling when someone asks if there’s anything you can do about the side effects destroying their self-esteem.
Meanwhile, the GLP-1 revolution is exploding. By late 2025, an estimated 6% of Americans—roughly 20 million people—were actively using GLP-1 medications like Ozempic, Wegovy, or compounded semaglutide for weight loss. That’s a 600% increase in just six years. And here’s the kicker: a 2023 survey found that nearly half of psychiatrists were already prescribing or recommending these drugs.
The demand is there. The clinical rationale is there. The question is: how do you turn this into a sustainable, scalable practice without burning out?
Let’s talk about the real economics, the regulatory landscape, and how to build a GLP-1 service line that actually works for your life.
Weight loss isn’t just about a shot once a week. It’s about motivation, adherence, navigating setbacks, managing anxiety around food, and addressing the psychological fallout when someone’s entire relationship with eating shifts overnight.
You spent years learning how to help people change ingrained patterns. You know how to spot emotional eating, binge behaviors, depression that tanks motivation, or the shame spiral that derails progress. Most obesity medicine providers don’t have that toolkit—you do.
If you prescribe antipsychotics, you’ve watched patients gain 30-60 pounds and felt helpless. If you treat depression, you know how weight gain compounds the problem—patients feel worse about themselves, stop going out, avoid the mirror. Some stop taking their psych meds because they can’t tolerate the metabolic effects.
By offering GLP-1 therapy, you’re solving a problem you created (or at least contributed to). Patients don’t have to choose between mental stability and physical health anymore. That’s powerful.
There are roughly 6,000 board-certified obesity medicine physicians in the US. Meanwhile, over 75% of American adults are overweight or obese, and tens of thousands of new patients are starting GLP-1s every week. The math doesn’t work—there aren’t enough specialists.
Psychiatrists stepping into this space face minimal competition, especially in telehealth. You’re not fighting for scraps; you’re meeting unmet demand with skills most providers don’t have.
Let’s be blunt: if you’ve heard you can acquire psychiatric or weight-loss patients for $30-50 each through DIY marketing, that’s fantasy.
Reality check on what patient acquisition actually costs:
Google Ads for mental health or weight-loss keywords: $15-40 per click. Most clicks don’t convert. A realistic cost per booked patient via PPC is $200-400+ when you factor in ad spend, testing, optimization, and no-shows.
SEO: Takes 6-12 months of consistent investment (content creation, backlinks, technical optimization) before you see meaningful patient flow. Unless you’re an SEO expert with time to burn, you’re hiring an agency at $2,000-5,000/month with uncertain ROI.
Psychology Today and Directory Listings: Monthly subscription fees ($30-100+), plus you’re competing with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking on top of subscription costs. Total monthly spend adds up fast, and conversion rates are unpredictable.
All-in DIY marketing: Between agency fees, ad spend, staff time to field and qualify leads, no-shows from cold traffic, and months of trial and error, the true cost to acquire a qualified patient who actually shows up is typically $200-500+.
For most solo providers or small groups, that’s a gamble. You’re spending thousands upfront with no guarantee of return.
This is where platforms like Klarity Health flip the equation. Instead of gambling $3,000-5,000/month on marketing that might work, you pay a standard listing fee per new patient appointment—only when a qualified patient books with you.
Here’s what that solves:
The business case is simple: Would you rather spend $5,000/month with uncertain ROI, or pay per appointment with guaranteed patient flow? For most providers—especially those starting out or scaling—the platform model removes risk entirely.
DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience. But for psychiatrists who want to focus on treating patients instead of becoming marketing experts, a pay-per-appointment model is the smart play.
The easiest patients to get are the ones you already have.
Medication reviews: When you’re adjusting an antipsychotic or mood stabilizer, bring up weight. ‘I know the Seroquel helped your mood, but I also know you’ve gained weight. Have you heard about the new medications for weight loss? I can prescribe those.’
Intake assessments: Add a BMI calculation and a simple question: ‘Is weight something you’d like help with?’ Many patients won’t bring it up unless you open the door.
Existing patient offers: Send a message via your patient portal or at the end of sessions: ‘I now offer medical weight management with GLP-1 medications. If you’re interested, let’s talk about it at your next visit.’
No additional marketing spend. Just offering a service people already want.
Joining a platform like Klarity puts you in front of thousands of patients actively searching for providers. These platforms invest heavily in advertising—Google, Facebook, SEO—and funnel qualified leads to enrolled providers.
You’re borrowing their patient acquisition engine. They handle the marketing, the screening, the booking. You show up and treat. It’s the fastest way to scale without building infrastructure yourself.
If you prefer to build your own brand, here’s what works:
SEO-focused content: Write blog posts like ‘Can Psychiatrists Prescribe Wegovy?’ or ‘Weight Gain from Psychiatric Meds: What You Can Do About It.’ Rank for long-tail keywords patients are searching. It takes time, but it’s free traffic.
Social media: Share patient success stories (with permission), education about GLP-1s, or posts addressing the mental health side of weight loss. Instagram and TikTok are goldmines for this content.
Referral relationships: Let local PCPs, endocrinologists, therapists, and dietitians know you offer GLP-1 prescribing. They have patients who need this service and don’t have bandwidth to manage it themselves.
Not every inquiry is a good fit. You want motivated patients who understand GLP-1s are tools, not magic. Screen for:
This prevents burnout from patients who ghost after the first visit or demand unrealistic results.
You must be licensed in the patient’s state. Period. This is non-negotiable for telehealth.
Psychiatrists (MD/DO): You can prescribe GLP-1s in any state where you hold a license. GLP-1s are not controlled substances, so the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can start patients entirely online.
PMHNPs and Psychiatric PAs: Scope depends on the state:
California: NPs need physician supervision unless they achieve independent ‘104 NP’ status (available starting 2026 after 3 years of supervised practice).
Texas: Strict collaborative agreement with a Texas physician required. One MD can supervise up to 7 APRNs/PAs.
Florida: Psych NPs need physician oversight. Florida’s autonomous APRN license applies only to primary care NPs, not psych.
New York: Experienced NPs (≥3,600 hours of practice) can prescribe independently.
Pennsylvania: All NPs need a collaborative agreement with a physician. No independent practice.
Illinois: NPs can achieve Full Practice Authority (FPA) after 4,000 hours of practice + 250 hours of additional education.
Bottom line for NPs: Know your state’s rules. If you need a supervising physician, many telehealth platforms will pair you with one. Don’t try to wing it—scope violations can cost your license.
GLP-1 prescribing via telehealth must meet the same standard as in-person care:
Document everything. If you’re prescribing off-label (common with semaglutide for obesity), note the clinical rationale and patient consent in the chart.
In 2023, there were reports of rare suicidal ideation possibly linked to GLP-1s. The FDA investigated and found no clear causal link, even directing removal of suicide warnings from labels by early 2026. Still, some patients worry.
This is where you shine. You’re a psychiatrist—you can monitor mood changes, assess for emerging depression or anxiety, and adjust psychiatric meds if needed. That’s a huge value-add most weight-loss clinics can’t offer.
Ask at every follow-up: ‘How’s your mood? Any changes in anxiety, sleep, or motivation?’ If something shifts, you’re equipped to handle it. That peace of mind keeps patients engaged and improves outcomes.
Most patients pay out-of-pocket for GLP-1 weight-loss therapy. Here’s why:
Insurance coverage is limited. Most insurers cover GLP-1s for diabetes, but weight-loss coverage is rare. As of 2024, only 13 state Medicaid programs (including California, Pennsylvania, and Illinois) covered GLP-1s for obesity. Many private plans exclude them entirely.
Medication costs vary widely. Brand-name Wegovy can be $1,300+/month without insurance. Compounded semaglutide (from licensed compounding pharmacies) might be $200-400/month. Patients need to know this upfront.
Cash-pay model pros:
Insurance model pros:
Reality: Most successful GLP-1 telehealth practices use a hybrid model. Charge cash for the initial consult (comprehensive evaluation, education, prescription). For follow-ups, bill insurance if the patient has coverage, or offer cash packages (e.g., $99/month for unlimited check-ins).
Be transparent about costs. Walk patients through their insurance benefits, help them estimate medication costs, and set expectations. Surprises kill retention.
The demand for GLP-1s is massive. If you’re not careful, you’ll drown in appointments and admin work. Here’s how to scale intelligently.
Use digital intake forms to gather history before the first visit:
This saves 15-20 minutes per appointment. You review the form, confirm key points on video, and move to treatment planning.
Create standardized order sets: A one-click ‘Obesity Intake Panel’ that orders A1c, fasting glucose, liver panel, TSH. Standardize your prescribing protocol—e.g., ‘Start semaglutide 0.25mg weekly for 4 weeks, titrate to 0.5mg at week 5 if tolerated.’
Templates and checklists prevent decision fatigue and ensure consistent care.
You don’t need to do everything yourself.
Medical assistants or RNs: Have them gather interim data (weight, BP, symptom questionnaires) before visits. They can also handle routine portal messages (‘Is nausea normal?’ → send pre-written response with coping tips).
Health coaches or dietitians: Use them for lifestyle counseling—diet planning, exercise coaching, motivational check-ins. You focus on medication management and mental health. Group telehealth sessions led by a coach can support multiple patients at once, reducing one-on-one counseling load.
Automation: Appointment reminders, online scheduling, automated follow-up surveys (‘How’s your nausea? Rate 1-10’). Some platforms offer AI-driven chatbots for FAQs, freeing up your time.
Team-based care isn’t just efficient—it improves outcomes. Patients get more touchpoints, more support, and you prevent burnout.
During the first 3-6 months, patients need monthly follow-ups for dose titration and side effect management. After that, visits can space to every 2-3 months once they’re stable.
Keep follow-ups brief: 15-20 minutes is enough to review weight, adjust dose, check mood, and answer questions. If you’ve standardized your approach, these visits are quick and predictable.
Retention strategy: Offer monthly support groups (virtual), educational materials, or access to a dietitian. This keeps patients engaged without adding to your direct workload.
Set firm availability hours for patient communication. Don’t answer messages at 10pm just because it’s telehealth. Use delayed replies or an answering service for after-hours.
Calibrate patient load gradually. Start with a few half-days per week dedicated to GLP-1 patients. As workflows smooth out, scale up. Don’t try to see 40 new patients in week one—you’ll burn out fast.
Monitor your own well-being. Signs of burnout—exhaustion, cynicism, feeling ineffective—should prompt a reassessment. Maybe you cap new intakes temporarily, hire a part-time NP to share the load, or adjust your schedule.
Flexibility is your friend. Research shows that greater schedule control and virtual practice options significantly reduce burnout. Telehealth lets you work from home, set your own hours, and avoid commute stress. Use that flexibility to protect your energy.
A good telehealth platform or EHR with integrated video, e-prescribing, and messaging will cut admin time significantly.
Remote monitoring tools—connected scales, apps where patients log weight weekly—let you track progress at a glance. You intervene only if trends are off. Many apps graph weight trends and medication adherence, turning a 10-minute data-gathering exercise into a 2-minute chart review.
Asynchronous check-ins can also work: ‘Send me your weight and any side effects via message. I’ll review and adjust your dose if needed.’ Not every follow-up needs a live video call.
Each state has quirks. Here’s what matters for the six priority states (full details in the table below).
California: NPs need supervision until 2026 when independent ‘104 NP’ licenses kick in. Telehealth requires patient consent (document it). Medi-Cal covers GLP-1s for obesity as of 2024, increasing insured patient demand.
Texas: Strict NP collaboration requirements. MDs can use the IMLC for expedited licensure. Texas allows pure telehealth relationships (no in-person visit required) as long as you meet standard of care.
Florida: Out-of-state MDs can register for telehealth without full Florida licensure. Psych NPs need physician oversight. High cash-pay market (Medicaid doesn’t cover GLP-1s for obesity).
New York: Experienced NPs (≥3,600 hours) can practice independently. Strong telehealth parity law encourages telemedicine. Large urban population but also rural shortages.
Pennsylvania: All NPs need physician collaboration. PA joined the IMLC (easier for MDs) and Nurse Licensure Compact (2025). Medicaid covers GLP-1s for obesity as of 2024.
Illinois: NPs can achieve Full Practice Authority after 4,000 hours + 250 hours of education. Telehealth parity law requires insurers to cover telemed like in-person. Medicaid covers GLP-1s for obesity.
Bottom line: If you’re practicing telehealth across multiple states, get licensed properly in each state where your patients are located. Don’t cut corners—board complaints are expensive and stressful.
Can psychiatrists legally prescribe GLP-1 medications like Ozempic or Wegovy?
Yes. Psychiatrists (MD/DO) have full prescriptive authority for GLP-1s in all states. These drugs are not controlled substances, so you can prescribe them via telehealth without restrictions. PMHNPs can also prescribe GLP-1s, but may need physician supervision depending on state scope-of-practice laws.
Do I need to see patients in person before prescribing GLP-1s via telehealth?
No. Because GLP-1s are not controlled substances, the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can establish a patient relationship and prescribe entirely via video consult, as long as you meet standard of care (comprehensive history, exam, informed consent).
What’s the typical cost to acquire a GLP-1 patient through marketing?
Realistic patient acquisition costs through DIY marketing (Google Ads, SEO, directories) are $200-500+ per booked patient when you factor in all expenses—ad spend, agency fees, staff time, no-shows, and testing. Platforms like Klarity use a pay-per-appointment model, eliminating upfront marketing spend and guaranteeing ROI—you only pay when a qualified patient shows up.
How often do GLP-1 patients need follow-up visits?
During the first 3-6 months (dose titration phase), plan for monthly follow-ups to monitor weight, adjust doses, and manage side effects. Once patients are stable on a maintenance dose, visits can space to every 2-3 months. Brief 15-20 minute check-ins are usually sufficient.
Will insurance cover GLP-1 medications for weight loss?
Coverage is limited. Most insurers cover GLP-1s for diabetes, but obesity coverage is rare. As of 2024, only 13 state Medicaid programs (including CA, PA, and IL) covered GLP-1s for weight loss. Many patients pay out-of-pocket, with brand-name medications costing $1,000+ per month or compounded semaglutide $200-400/month.
Can psychiatric NPs prescribe GLP-1s independently?
It depends on the state. In New York and Illinois, experienced NPs can achieve independent practice authority. In California (starting 2026), Texas, Florida, and Pennsylvania, NPs need physician collaboration agreements to prescribe. Check your state’s scope-of-practice laws and ensure proper supervision if required.
Are there psychiatric side effects I should monitor with GLP-1s?
Early reports suggested rare links to suicidal ideation, but the FDA found no clear causal relationship and removed suicide warnings by 2026. Still, as a psychiatrist, you’re uniquely positioned to monitor mood, anxiety, and motivation changes during treatment. Ask about mental health at every follow-up—it’s a value-add most weight-loss clinics can’t provide.
What labs or workup do I need before starting a patient on a GLP-1?
Standard workup includes:
Document informed consent, especially if prescribing off-label (e.g., using Ozempic for obesity instead of Wegovy).
How do I prevent burnout when scaling a GLP-1 practice?
Use standardized workflows (digital intake forms, templated order sets), delegate tasks (health coaches for lifestyle counseling, MAs for data gathering), automate where possible (reminders, online scheduling), and set firm boundaries (limited availability hours, gradual patient load increases). Leverage telehealth flexibility to protect your schedule and energy.
The obesity epidemic isn’t going away. GLP-1 demand is only increasing. Patients are desperate for providers who understand both the medical and psychological sides of weight loss.
You already have the skills. You already have patients who need this. The infrastructure—telehealth platforms, compounding pharmacies, EHR tools—exists to support you.
What’s stopping you?
If you’re ready to add GLP-1 services to your practice without the headache of building patient acquisition from scratch, Klarity Health offers a turnkey solution. Pre-qualified patients matched to your availability. Built-in telehealth infrastructure. Pay-per-appointment pricing that eliminates upfront risk.
You focus on treating patients. We handle the rest.
Ready to get started? Join Klarity’s provider network and start seeing GLP-1 patients this week. No marketing spend, no long-term contracts, no gambles. Just patients who need your expertise.
Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage). Published May 27, 2025. www.axios.com
ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ Published October 20, 2025. www.confectionerynews.com
Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ Published August 22, 2025. time.com
Axios – ‘America’s doctors need more obesity medicine training.’ Published May 28, 2024. www.axios.com
Axios – ‘States slow to cover GLP-1s for weight loss’ (citing KFF policy report). Published November 5, 2024. www.axios.com
Find the right provider for your needs — select your state to find expert care near you.